drugset / Trial / NCT03889366
Relative Bioavailability of NXP001 Compared to Emend® in Healthy Volunteers
RandomizedCrossoverOpen-labelOther
Summary
This study will compare the relative bioavailability of both an oral capsule formulation and an oral suspension formulation of NXP001 to Emend® in healthy male volunteers in the fasted state.
Timeline
- Start
- 2019-03-20
- Primary completion
- 2019-04-15
- Completion
- 2019-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aprepitant | Other / unclassified | 125 mg | Oral |
Indications
No indication recorded.